SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Feb-24 7:53 PM View: | Moonlake Immunotherapeutics (MLTX) | 28-Feb-24 | Sale (Planned) | 31,910 | $55.00 | $1,755,050.00 | (1%) 3.03M to 3.0M | |
29-Feb-24 7:53 PM View: | Moonlake Immunotherapeutics (MLTX) | 28-Feb-24 | Sale (Planned) | 28,090 | $55.00 | $1,544,950.00 | (< 1%) 3.0M to 2.97M | |
29-Feb-24 7:53 PM View: | Moonlake Immunotherapeutics (MLTX) | 27-Feb-24 | Private Sale (Planned) | 29,491 | $55.00 | $1,622,000.00 | (< 1%) 3.09M to 3.06M | |
29-Feb-24 7:53 PM View: | Moonlake Immunotherapeutics (MLTX) | 27-Feb-24 | Sale (Planned) | 29,431 | $55.00 | $1,618,700.00 | (< 1%) 3.06M to 3.03M | |
22-Feb-24 6:32 PM View: | Moonlake Immunotherapeutics (MLTX) | 21-Feb-24 | Sale (Planned) | 509 | $55.31 | $28,152.80 | (< 1%) 3.09M to 3.09M | |
22-Feb-24 6:32 PM View: | Moonlake Immunotherapeutics (MLTX) | 21-Feb-24 | Sale (Planned) | 569 | $55.30 | $31,465.70 | (< 1%) 3.09M to 3.09M | |
22-Feb-24 6:32 PM View: | Moonlake Immunotherapeutics (MLTX) | 20-Feb-24 | Private Sale (Planned) | 10,000 | $57.45 | $574,500.00 | (< 1%) 3.11M to 3.1M | |
22-Feb-24 6:32 PM View: | Moonlake Immunotherapeutics (MLTX) | 20-Feb-24 | Sale (Planned) | 10,000 | $57.43 | $574,300.00 | (< 1%) 3.1M to 3.09M | |
16-Feb-24 6:02 PM View: | Moonlake Immunotherapeutics (MLTX) | 16-Feb-24 | Sale (Planned) | 10,000 | $60.15 | $601,500.00 | (< 1%) 3.13M to 3.12M | |
16-Feb-24 6:02 PM View: | Moonlake Immunotherapeutics (MLTX) | 16-Feb-24 | Sale (Planned) | 10,000 | $60.15 | $601,500.00 | (< 1%) 3.12M to 3.11M | |
16-Feb-24 6:02 PM View: | Moonlake Immunotherapeutics (MLTX) | 15-Feb-24 | Sale (Planned) | 10,000 | $60.17 | $601,700.00 | (< 1%) 3.15M to 3.14M | |
16-Feb-24 6:02 PM View: | Moonlake Immunotherapeutics (MLTX) | 15-Feb-24 | Sale (Planned) | 10,000 | $60.16 | $601,600.00 | (< 1%) 3.14M to 3.13M | |
16-Feb-24 6:02 PM View: | Moonlake Immunotherapeutics (MLTX) | 14-Feb-24 | Private Sale (Planned) | 10,000 | $62.42 | $624,200.00 | (< 1%) 3.17M to 3.16M | |
16-Feb-24 6:02 PM View: | Moonlake Immunotherapeutics (MLTX) | 14-Feb-24 | Sale (Planned) | 10,000 | $62.43 | $624,300.00 | (< 1%) 3.16M to 3.15M | |
03-Oct-23 10:00 PM View: | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Conversion | 2,527,480 | -- | -- | 75% 3.36M to 5.89M | |
03-Oct-23 10:00 PM View: | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Conversion | 41,981 | -- | -- | < 1% 5.89M to 5.93M | |
03-Oct-23 10:00 PM View: | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Disposition | 2,527,480 | -- | -- | (43%) 5.93M to 3.41M | |
03-Oct-23 10:00 PM View: | Moonlake Immunotherapeutics (MLTX) | 01-Oct-23 | Disposition | 41,981 | -- | -- | (1%) 3.41M to 3.36M | |
07-Apr-23 4:05 PM View: | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Conversion | 500,006 | -- | -- | 15% 3.36M to 3.86M | |
07-Apr-23 4:05 PM View: | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Conversion | 98,090 | -- | -- | 3% 3.86M to 3.96M | |
07-Apr-23 4:05 PM View: | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Disposition | 500,006 | -- | -- | (13%) 3.96M to 3.46M | |
07-Apr-23 4:05 PM View: | Moonlake Immunotherapeutics (MLTX) | 05-Apr-23 | Disposition | 98,090 | -- | -- | (3%) 3.46M to 3.36M |